Isolated office hypertension: A 3-year follow-up study

Blood Pressure

Volumn 14, Issue 5, 2005, Pages 298-305

  Grandi, Anna M ^a,b   Solbiati, Francesco ^a   Laurita, Emanuela ^a   Cassinerio, Elena ^a   Marchesi, Chiara ^a   Piperno, Francesca ^a   Maresca, Andrea ^a   Guasti, Luigina ^a   Venco, Achille ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b NONE   (Italy)

Author keywords

Ambulatory BP monitoring; Diastolic function; Isolated office hypertension; Left ventricular hypertrophy

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; DIASTOLE; DISEASE COURSE; DISEASE MARKER; ECHOCARDIOGRAPHY; FOLLOW UP; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; WHITE COAT HYPERTENSION;

ADULT; BLOOD PRESSURE MONITORING, AMBULATORY; CASE-CONTROL STUDIES; DIASTOLE; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MIDDLE AGED; OFFICE VISITS; RISK FACTORS;

EID: 28244472007     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.1080/08037050500331496     Document Type: Article

References (29)

1. Verdecchia P, O'Brien E, Pickering T, Staessen JA, Parati G, Myers M, et al. European Society of Hypertension Working Group on Blood Pressure Monitoring. When can the practicing physician suspect white-coat hypertension? Statement from the Working Group on Blood Pressure Monitoring of the European Society of Hypertension. Am J Hypertension. 2003;16:87-91.
2. Gosse P, Promax H, Durandet P, Clementy J. "White coat" hypertension: No harm for the heart. Hypertension. 1993;22:766-770.
3. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Zampi I, Gattobigio R, et al. White coat hypertension and white coat effect. Similarities and differences. Am J Hypertens. 1995;8:790-798.
4. Cavallini MC, Roman MJ, Pickering TG, Schwartz JE, Pini R, Devereux RB. Is white coat hypertension associated with arterial disease or left ventricular hypertrophy? Hypertension. 1995;26:413-419.
5. Glen SK, Elliott HL, Curzio JL, Lees KR, Reid JL. White-coat hypertension as a cause of cardiovascular dysfunction. Lancet. 1996;348:654-657.
6. Muscholl MW, Hense HW, Brockel U, Doring A, Riegger GA, Schunkert H. Changes in left ventricular structure and function in patients with white-coat hypertension: Cross sectional survey. BMJ. 1998;317:565-570.
7. Muldoon MF, Nazzaro P, Sutton-Tyrrel K, Manuck SB. White-coat hypertension and carotid artery atherosclerosis: A matching study. Arch Intern Med. 2000;160:1507-1512.
8. Grandi AM, Broggi R, Colombo S, Santillo R, Imperiale D, Bertolini A, et al. Left ventricular changes in isolated office hypertension: A blood pressure matched comparison with normotension and sustained hypertension. Arch Intern Med. 2001;161:2677-2681.
9. Karter Y, Curgunlu A, Altinisik S, Erturk N, Vehid S, Mihmanli I, et al. Target organ damage and changes in arterial compliance in white coat hypertension. Is white coat innocent? Blood Press. 2003;12:307-313.
10. Strandberg TE, Salomaa V. White coat effect, blood pressure and mortality in men: Prospective cohort study. Eur Heart J. 2000;21:1714-1718.
11. Gustavsen PH, Hoegholm A, Bang LE, Kristensen KS. White coat hypertension is a cardiovascular risk factor: A 10-year follow-up study. J Hum Hypertens. 2003;17:811-817.
12. Verdecchia P, Reboldi GP, Angeli F, Schillaci G, Schwartz JE, Pickering TG, et al. Short-and long-term incidence of stroke in white-coat hypertension. Hypertension. 2005;45:1-6.
13. Bidlingmeyer I, Burnier M, Bidlingmeyer M, Waeber B, Brunner HR. Isolated office hypertension: A prehypertensive state? J Hypertens. 1996;14:327-332.
14. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Sacchi N, et al. Identification of subjects with white-coat hypertension and persistently normal ambulatory blood pressure. Blood Press Monit. 1996;1:217-222.
15. Polonia JJ, Santos AR, Gama GM, Basto F, Bettencourt PM, Martins LR. Follow-up clinic and ambulatory blood pressure in untreated white-coat hypertensive patients (evaluation after 2-5 years). Blood Press Monit. 1997;2:289-295.
16. Upton MT, Gibson DG. The study of left ventricular function from digitized echocardiograms. Prog Cardiovasc Dis. 1978;20:359-384.
17. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: Validation of the method. Circulation. 1977;55:613-618.
18. Verdecchia P, Schillaci G, Boldrini F, Zampi I, Porcellati C. Variability between current definitions of "normal" ambulatory blood pressure: Implications in the assessment of white coat hypertension. Hypertension. 1992;20:555-562.
19. Khoury S, Yarows SA, O'Brien TK, Sowers JR. Ambulatory blood pressure monitoring in a nonacademic setting: Effect of age and sex. Am J Hypertens. 1992;5:616-623.
20. Mancia G, Sega R, Bravi C, De Vito G, Valagussa F, Cesana G, et al. Ambulatory blood pressure normality: Results from the PAMELA study. J Hypertens. 1995;13:1377-1390.
21. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Porcellati C. White coat hypertension: Not guilty when correctly defined. Blood Press Monit. 1998;3:147-152.
22. Verdecchia P, Staessen JA, White WB, Imai Y, O'Brien ET. Properly defining white coat hypertension. Eur Heart J. 2002;23:106-109.
23. Pickering TG, Coats A, Mallion JM, Mancia G, Verdecchia P. Blood pressure monitoring. Task force V: White-coat hypertension. Blood Pressure Monit. 1999;4:333-341.
24. Middeke M, Lemmer B. Office hypertension: Abnormal blood pressure regulation and increased sympathetic activity compared with normotension. Blood Press Monit. 1996;1:403-407.
25. Smith PA, Graham LN, Mackintosh AF, Stoker JB, Mary DA. Sympathetic neural mechanisms in white-coat hypertension. J Am Coll Cardiol. 2002;40:126-132.
26. Lee JS, Kawakubo K, Kashihara H, Mori K. Effect of longterm body weight change on the incidence of hypertension in Japanese men and women. Int J Obes Relat Metab Disord. 2004;28:391-395.
27. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non hypertensives participants in the Framingham Heart Study: A cohort study. Lancet. 2001;358:1682-1686.
28. Rakowski H, Appleton C, Chan YL, Dumesnil JG, Honos G, Jue J, et al. Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography. J Am Soc Echocardiogr. 1996;9:736-760.
29. Lee CH, Hogan JC, Gibson DG. Diastolic disease in left ventricular hypertrophy: Comparison of M-mode and Doppler echocardiography for the assessment of rapid ventricular filling. Br Heart J. 1991;65:194-200.